Blair Lawley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Blair Lawley has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Kai Lee
Department of Microbiology and Immunology, University of Otago, Dunedin 9016, New Zealand
1 shared publication - Laura N. Burga
Department of Microbiology and Immunology, University of Otago, Dunedin 9016, New Zealand
1 shared publication - Miguel Eduardo Quinones-Mateu
Department of Microbiology and Immunology, Western University
1 shared publication - Mihnea Bostina
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
1 shared publication - Shakeel Waqqar
Department of Microbiology and Immunology, University of Otago, Dunedin 9016, New Zealand
1 shared publication - Timothy P. Bilton
AgResearch, Invermay Agricultural Centre, Mosgiel, New Zealand
1 shared publication
Latest Publications
- Open Access
Directed Evolution of Seneca Valley Virus in Tumorsphere and Monolayer Cell Cultures of a Small-Cell Lung Cancer Model
The Seneca Valley virus (SVV) is an oncolytic virus from the picornavirus family, characterized by a 7.3-kilobase RNA genome encoding for all the structural and functional viral proteins. Directed evolution by serial passaging has been employed for oncolytic virus adaptation to increase the killing efficacy towards certain types of tumors. We propagated the SVV in a small-cell lung cancer model under two culture conditions: conventional cell monolayer and tumorspheres, with the latter resembling more closely the cellular structure of the tumor of origin. We observed an increase of the virus-killing efficacy after ten passages in the tumorspheres. Deep sequencing analyses showed genomic changes in two SVV populations comprising 150 single nucleotides variants and 72 amino acid substitutions. Major differences observed in the tumorsphere-passaged virus population, compared to the cell monolayer, were identified in the conserved structural protein VP2 and in the highly variable P2 region, suggesting that the increase in the ability of the SVV to kill cells over time in the tumorspheres is acquired by capsid conservation and positively selecting mutations to counter the host innate immune responses.
Open AccessDirected Evolution of Seneca Valley Virus in Tumorsphere and Monolayer Cell Cultures of a Small-Cell Lung Cancer Model
The Seneca Valley virus (SVV) is an oncolytic virus from the picornavirus family, characterized by a 7.3-kilobase RNA genome encoding for all the structural and functional viral proteins. Directed evolution by serial passaging has been employed for oncolytic virus adaptation to increase the killing efficacy towards certain types of tumors. We propagated the SVV in a small-cell lung cancer model under two culture conditions: conventional cell monolayer and tumorspheres, with the latter resembling more closely the cellular structure of the tumor of origin. We observed an increase of the virus-killing efficacy after ten passages in the tumorspheres. Deep sequencing analyses showed genomic changes in two SVV populations comprising 150 single nucleotides variants and 72 amino acid substitutions. Major differences observed in the tumorsphere-passaged virus population, compared to the cell monolayer, were identified in the conserved structural protein VP2 and in the highly variable P2 region, suggesting that the increase in the ability of the SVV to kill cells over time in the tumorspheres is acquired by capsid conservation and positively selecting mutations to counter the host innate immune responses.